Trials / Unknown
UnknownNCT04094714
CHACO Study: Control of Arterial Hypertension in Colombian Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,100 (estimated)
- Sponsor
- Scandinavia Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.
Detailed description
OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment. MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.
Conditions
Timeline
- Start date
- 2019-06-27
- Primary completion
- 2023-12-01
- Completion
- 2024-07-01
- First posted
- 2019-09-19
- Last updated
- 2019-09-23
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT04094714. Inclusion in this directory is not an endorsement.